Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.4600 (3.9%) ($7.2100 - $7.4600) on Fri. Jul. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 62 | Latest Price | $7.4600(3.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(31%) VCIT(25%) BND(24%) BNDX(23%) LQD(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.43% in a week (0% probabilities). XLRE(-31%) XLP(-28%) DIA(-24%) XLV(-21%) XLI(-21%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.28(2.47%) | 10 Day Moving Average | $7.27(2.61%) | 20 Day Moving Average | $7.16(4.19%) | To recent high | -15.8% | To recent low | 7.5% | Market Cap | $1.316b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |